Repligen | RGEN - 税前利润

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.49

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 6.69B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

164.06

USD 17.11M

USD 197.91M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	税前利润	更改		日
Agilent	USD 442M		1000K	2025-09
Align Technology	USD 176.6M		81.86M	2025-12
Bio Techne	USD 84.99M		107.85M	2025-09
BioMarin Pharmaceutical	USD -26.32M		324.19M	2025-09
Bristol-Myers Squibb	USD 3.11B		1.34B	2025-09
Bruker	USD -72.6M		73.1M	2025-09
Charles River Laboratories	USD 170.03M		98.62M	2025-09
Danaher	USD 1.08B		421M	2025-09
Dentsply International	USD -230M		77M	2025-09
Exact Sciences	USD -17.76M		17.7M	2025-09
General Electric Aerospace	USD 2.85B		337M	2025-12
Henry Schein	USD 137M		16M	2025-09
Illumina	USD 220M		86M	2025-09
IQVIA Holdings	USD 6.16B		5.84B	2025-09
Mettler Toledo International	USD 269.24M		20.58M	2025-09
Myriad Genetics	USD 6.2M		2.1M	2024-12
OraSure Technologies	USD -234K		3.37M	2024-06
Pacific Biosciences Of California	USD -60.72M		112.59M	2024-09
Pfizer	USD 3.33B		290M	2025-09
Repligen	USD 17.11M		10.25M	2025-09
Revvity	USD 55.68M		115.97M	2025-09
Standard Biotools	USD -32.9M		14.62M	2025-09
Thermo Fisher Scientific	USD 2.12B		295M	2025-12
Waters	USD 170.12M		7.57M	2025-09
West Pharmaceutical Services	USD 170.1M		8.1M	2025-09